111's revenue for the
three
months ended in Mar. 2026 was $343 Mil.
Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was $1,611 Mil.
111's Revenue per Share for the
three
months ended in Mar. 2026 was $38.96.
Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $184.48.
Warning Sign:
111 Inc revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of 111 was -20.40% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -4.20% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 4.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 10 years, 111's highest 3-Year average Revenue per Share Growth Rate was 103.70% per year. The lowest was -4.20% per year. And the median was 50.10% per year.
111 (NAS:YI) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
111 Revenue Related Terms
111 Revenue Historical Data
* Premium members only.
The historical data trend for 111's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, 111's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
111 Revenue vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, 111's Revenue distribution charts can be found below:
* The bar in red indicates where 111's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,611 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
111 (YI) has a Revenue of $1,611 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on 111 and its competitors.
Is 111's Revenue too high?
111's current Revenue is $1,611 Mil. Overall, 111 has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does 111's Revenue compare to COSM and HKPD?
111's Revenue of $1,611 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Medical Distribution company?
A good Revenue depends on the Medical Distribution industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on 111 and its competitors. 111's current Revenue is $1,611 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 111 stock overvalued right now?
Based on GuruFocus' analysis, 111 (YI) is currently considered Possible Value Trap. The stock's GF Value™ is $6.66, compared to a current price of $4.01 — trading 39.8% below its estimated fair value. The current Revenue is $1,611 Mil. 111's overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For 111 (YI), the current Revenue is $1,611 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 111 (YI) Overvalued in 2026?
Based on GuruFocus' analysis, 111 stock appears to be undervalued.
The current stock price of $4.01 is trading 39.8% below its estimated GF Value™ of $6.66.
GuruFocus considers 111 to be Possible Value Trap.
Key valuation signals for YI:
Revenue: $1,611 Mil
GF Value™: $6.66 vs. price of $4.01 (39.8% below fair value)
No single metric tells the full story. See the YI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.
56GF Score
Get the complete analysis for YI
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
YI has been successfully added to your 
